Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(29%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
5
71%
Ph phase_2
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Recruiting2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (16.7%)
N/A5 (83.3%)

Trials by Status

not_yet_recruiting114%
completed343%
terminated114%
recruiting229%

Recent Activity

2 active trials
Showing 5 of 7
not_yet_recruitingnot_applicable

PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer

NCT07130344
recruitingnot_applicable

Diagnostic Interest of Bone Tomoscintigraphy in the Search for Cervical Pseudarthrosis

NCT07140432
completedphase_2

AR and ER Imaging in Metastatic Breast Cancer

NCT01988324
recruitingnot_applicable

Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy

NCT04849754
completed

Is Bone Scintigraphy Necessary in cT1N0M0 GGO Non-Small Cell Lung Cancer? (ECTOP-1006)

NCT03689439
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07130344Not Applicable

PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer

Not Yet Recruiting
NCT07140432Not Applicable

Diagnostic Interest of Bone Tomoscintigraphy in the Search for Cervical Pseudarthrosis

Recruiting
NCT01988324Phase 2

AR and ER Imaging in Metastatic Breast Cancer

Completed
NCT04849754Not Applicable

Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy

Recruiting
NCT03689439

Is Bone Scintigraphy Necessary in cT1N0M0 GGO Non-Small Cell Lung Cancer? (ECTOP-1006)

Completed
NCT03497078Not Applicable

Comparison of Image Quality Between New Collimator LEHRS vs Siemens LEHR on Bone Scintigraphy

Completed
NCT01322256Not Applicable

PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
7